Conjugation of organoruthenium(II) 3-(1H-benzimidazol-2-yl)pyrazolo[3,4-b]pyridines and indolo[3,2-d]benzazepines to recombinant human serum albumin: a strategy to enhance cytotoxicity in cancer cells.
about
In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancerMirror-image organometallic osmium arene iminopyridine halido complexes exhibit similar potent anticancer activity.Application of imaging mass spectrometry approaches to facilitate metal-based anticancer drug research.Developing an anticancer copper(II) pro-drug based on the nature of cancer cell and human serum albumin carrier IIA subdomain: mouse model of breast cancer.Ruthenium(ii) p-cymene complexes of a benzimidazole-based ligand capable of VEGFR2 inhibition: hydrolysis, reactivity and cytotoxicity studies.Ruthenium-Arene-β-Carboline Complexes as Potent Inhibitors of Cyclin-Dependent Kinase 1: Synthesis, Characterization and Anticancer Mechanism Studies.Synthesis, characterisation and in vitro anticancer activity of hexanuclear thiolato-bridged arene ruthenium metalla-prisms.Ruthenium- and osmium-arene complexes of 8-substituted indolo[3,2-c]quinolines: Synthesis, X-ray diffraction structures, spectroscopic properties, and antiproliferative activity.Spectroscopic Study of the Interactions of Ruthenium-Ketoconazole Complexes of Known Antiparasitic Activity with Human Serum Albumin and Apotransferrin.Effects of bidentate coordination on the molecular properties rapta-C based complex using theoretical approach.Computational properties of η6-toluene and η6-trifluorotoluene half-sandwich Ru(II) anticancer complexes.Spectroscopic investigation and in vitro cytotoxic activity toward HepG2 cells of a copper compound complexed with human serum albumin.The Anticancer Activities of Some Nitrogen Donor Ligands Containing bis-Pyrazole, Bipyridine, and Phenanthroline Moiety Using Docking Methods.Insights into the Intramolecular Properties ofη6-Arene-Ru-Based Anticancer Complexes Using Quantum Calculations
P2860
Q30398565-4A4F56B8-0B3A-4DEC-A3DF-C262A6C8A0B5Q34795234-3B2FD286-1B9F-4F03-BBD2-F32E43D67607Q36268494-FEEC250A-AA20-4707-91DE-D502D99E6595Q37687110-32399D32-4D80-4537-B7D5-DC81C46960D1Q38699445-D46C73E6-8692-4DF9-A3BF-86A6FBED5723Q39121561-70BBDE32-12D5-4F94-A622-E0F4040CF7A3Q39205740-DF983981-19CD-435A-9DF4-B133C7EC2440Q41642755-1D5A05BF-E72A-47C6-9EC8-7CFDC7EC2590Q41849496-547B8623-759A-4387-95DE-C23C520B43C0Q43756596-85C7369D-00F0-4583-A31E-D657FB85DAF0Q46014374-4A401450-B65D-41A4-9A8E-B6D3EA20FB18Q47904094-CF7FB434-50E6-40B8-94F3-B19D2BE7CB1AQ55394029-29E3935E-6F12-42AA-AE3B-A6308B1CCFA4Q59011264-27BC88F1-FD46-4AA7-A4F2-F6C4C427F810
P2860
Conjugation of organoruthenium(II) 3-(1H-benzimidazol-2-yl)pyrazolo[3,4-b]pyridines and indolo[3,2-d]benzazepines to recombinant human serum albumin: a strategy to enhance cytotoxicity in cancer cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Conjugation of organoruthenium ...... cytotoxicity in cancer cells.
@ast
Conjugation of organoruthenium ...... cytotoxicity in cancer cells.
@en
type
label
Conjugation of organoruthenium ...... cytotoxicity in cancer cells.
@ast
Conjugation of organoruthenium ...... cytotoxicity in cancer cells.
@en
prefLabel
Conjugation of organoruthenium ...... cytotoxicity in cancer cells.
@ast
Conjugation of organoruthenium ...... cytotoxicity in cancer cells.
@en
P2093
P2860
P50
P356
P1433
P1476
Conjugation of organoruthenium ...... cytotoxicity in cancer cells.
@en
P2093
Fabio Edafe
Iryna N Stepanenko
Maria S Novak
Vladimir B Arion
P2860
P304
12669-12679
P356
10.1021/IC201801E
P407
P577
2011-11-23T00:00:00Z